Next Issue
Volume 26, 01
Previous Issue
Volume 25, 09
 
 
cardiovascmed-logo

Journal Browser

Journal Browser
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 25, Issue 6 (11 2022) – 5 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
6 pages, 1817 KB  
Review
PCI in the Management of Chronic Coronary Syndromes After the ISCHEMIA Study
by Thabo Mahendiran, David Meier, Stéphane Fournier and Olivier Muller
Cardiovasc. Med. 2022, 25(6), w10118; https://doi.org/10.4414/cvm.2021.02189 - 1 Nov 2022
Abstract
The role of percutaneous coronary intervention (PCI) in the management of chronic coronary syndromes (CCS) has long been a subject of debate. Numerous clinical trials have demonstrated limited benefit from revascularisa-ion on hard clinical endpoints among patients with CCS. The latest of these [...] Read more.
The role of percutaneous coronary intervention (PCI) in the management of chronic coronary syndromes (CCS) has long been a subject of debate. Numerous clinical trials have demonstrated limited benefit from revascularisa-ion on hard clinical endpoints among patients with CCS. The latest of these studies, the International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches (ISCHEMIA) trial, found no significant reduction in mortality or myocardial infarction from revascularisation in patients with CCS when compared with optimal medical therapy (OMT) alone. At face value, these results suggest that patients with significant ischaemia on stress testing no longer need to be rushed to the catheterisation labora-ory. Instead, the focus should be on the instigation of guideline-recommended OMT, with PCI reserved for patients who remain symptomatic despite OMT. This article provides a review of the current evidence, including the findings of the ISCHEMIA trial, and assesses the potential implications for future clinical practice. Full article
Show Figures

Figure 1

4 pages, 5196 KB  
Case Report
Calcium Channel Blockers for Coronary Vasospasm with Sudden Cardiac Arrest–A Case Report
by Daniel Sepulcri, Ian Russi, Federico Moccetti, Stefan Toggweiler, Florim Cuculi, Benjamin Berte, Richard Kobza and Matthias Bossard
Cardiovasc. Med. 2022, 25(6), w10116; https://doi.org/10.4414/cvm.2021.02187 - 1 Nov 2022
Abstract
Coronary vasospasm is often considered a rather benign condition. But one needs to take into account that they can trigger severe myocardial ischaemia causing ventricular arrhythmias and sudden cardiac arrest. Introduction of effective treatments, including calcium channel blockers are key. But individual response [...] Read more.
Coronary vasospasm is often considered a rather benign condition. But one needs to take into account that they can trigger severe myocardial ischaemia causing ventricular arrhythmias and sudden cardiac arrest. Introduction of effective treatments, including calcium channel blockers are key. But individual response to various calcium channel blockers may differ. Full article
Show Figures

Figure 1

2 pages, 1443 KB  
Editorial
The London Postgraduate Course in Heart Failure
by Ruth Amstein, Christine Lohman and Thomas F. Lüscher
Cardiovasc. Med. 2022, 25(6), 191; https://doi.org/10.4414/cvm.2022.02265 - 1 Nov 2022
Viewed by 68
Abstract
Heart failure is the final common pathway of most cardiac conditions[...] Full article
Show Figures

Figure 1

2 pages, 1521 KB  
Editorial
The Zurich Postgraduate Course in Heart Failure Now in Its Fifth Edition
by Andreas J. Flammer, Valérie Streichenberg and Frank Ruschitzka
Cardiovasc. Med. 2022, 25(6), 190; https://doi.org/10.4414/cvm.2022.02264 - 1 Nov 2022
Viewed by 81
Abstract
Heart failure is an emerging epidemic owing to the growing and ageing population.[...] Full article
Show Figures

Figure 1

5 pages, 500 KB  
Review
Extracorporeal Life Support Use in Cardiac and Circulatory Failure: A Summary of Recently Published S3 Guidelines
by Omer Dzemal, Christoph Starck, Lukas Wessel, Oliver Miera, Karl Werdan, Marion Burckhardt, Ralf Muellenbach, Rolf Jaksties, Florian Schmidt, Karsten Wiebe, Christof Schmid, Stefan Kluge, Kevin Pilarczyk, Nils Haake, Thomas Schaible, Andreas Flemmer, Stefan Klotz, Alexander Assmann, Uwe Janssens, Matthias Lubnow, Susanne Herber-Jonat, Markus Ferrari, Dirk Buchwald, Stephan Ensminger, York Zausig, Andreas Beckmann, Mark Rosenberg, Malte Kelm, Marcus Hennersdorf, Christiane Hartog, Stefan Fischer, Ardawan Rastan, Daniel Zimpfer, Andreas Fründ, Sven Maier, Elfriede Ruttmann-Ulmer, Heinrich Groesdonk, Christian Schlensak, Monika Nothacker, Michael Buerke, Harald Köditz, Guido Michels, Lars Krüger and Udo Boekenadd Show full author list remove Hide full author list
Cardiovasc. Med. 2022, 25(6), 165; https://doi.org/10.4414/cvm.2022.02234 - 1 Nov 2022
Viewed by 63
Abstract
Introduction. Extracorporeal life support (ECLS) represents a widely accepted treatment modality for patients with cardiac and/or respiratory failure failing to respond to conventional medical therapy [...] Full article
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop